E-DRUG: KEI roundtable on manufacturing capacity for COVID-19 vaccines
--------------------------------------------------------------------------
KEI roundtable on pathways to scale up manufacturing capacity for COVID-19
vaccines
Friday, 19 February 2021
14h00 UTC to 16h00 UTC
15h00 CET to 17h00 CET
On Friday, 19 February 2021, KEI will host a virtual roundtable to discuss
pathways to scale production, increase competition and speed the delivery
of COVID-19 vaccines. This roundtable will provide experts and policymakers
the opportunity to exchange views on the challenges and opportunities to
scale production of COVID-19 vaccines. This dialogue will encourage experts
to address practical issues for the transfer of know-how and technology for
manufacturing.
To register:
vaccine-roundtable@keionline.org
Questions and topics to be raised include:
- Which vaccines represent the most significant opportunities in terms
of scaling manufacturing capacity and enhancing access?
- What incentives, mandates and/or subsidies are useful in expanding
access to vaccine manufacturing know-how and capacity?
- What is currently known about global manufacturing capacity for each
relevant COVID-19 vaccine, and what measures are necessary to bring a
facility into good manufacturing practice compliance for production of
specific vaccines and other COVID-19 health technologies?
- What is the WHO prequalification program doing regarding COVID-19
vaccines?
- What is the WHO C-TAP doing to expand manufacturing for COVID-19
vaccines?
- What is the Medicines Patent Pool doing to expand manufacturing for
COVID-19 vaccines?
- What are national governments doing to scale and expand vaccine
manufacturing access?
- What mistakes were made in 2020, and what mistakes need to be avoided
in 2021?
Thiru Balasubramaniam
Knowledge Ecology International
Geneva
<thiru@keionline.org>